PlainRecalls

Denton Pharma, Inc.

Compiled from official public sources by the publisher.

4 recalls on record · Latest: Nov 11, 2020

Subscribe to new Denton Pharma, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Denton Pharma, Inc. LIGHT-BOOK · SINGLE-AGENCY

#2,857 of 14,151 · 4 notices · 0.004% archive

  • BOOK 4 notices
  • RANK #2,857 of 14,151
  • SHARE 0.004% archive
  • AGENCY FDA Drug (4)
  • CAT drugs
  • CATS 2 categories
  • LATEST Nov 11, 2020
  • PHOTO 1 Epic, LLC

Nearest notice-volume peer: 1 Epic, LLC (0 notice gap)

Denton Pharma, Inc. accounts for about 0.004% of the 104,423-notice archive on 4 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Denton Pharma, Inc. sits among 14,151 recalling firms

Denton Pharma, Inc. ranks 2,857th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Denton Pharma, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

4 2857th of 14151 higher than 10,859 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Denton Pharma, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Denton Pharma, Inc. holds about 0.004% of archive notices alongside 4 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Nov 11, 2020

Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, a) 30 count (NDC 70934-309-30); b) 60 count (NDC 70934-309-60); c) 90 count (70934-309-90); d) 120 count (NDC 70934-309-98) bottles, Rx Only, Time-Cap Labs Inc. Repackaged by Northwind Pharmaceuticals North Blenheim, NY 12131
FDA Drug Moderate Nov 11, 2020

Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only, Time-Cap Labs, Inc., Repackaged By: Northwind Pharmaceuticals North Blenheim NY 12131 NDC 70934-334-30
FDA Drug Moderate Jan 29, 2020

Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDC 70934-017-20), c). 24-count bottle (NDC 70934-017-24) d). 30-count bottle (NDC 70934-017-30) e). 90-count bottle (NDC 70934-017-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131.
FDA Drug Moderate Jan 29, 2020

Ranitidine Tablets, USP 300 mg a). 15-count bottles (NDC 70934-287-15), b). 90-count bottles (NDC 70934-287-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131

Denton Pharma, Inc. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (4 here).

1 Epic, LLC 4 3rd Day Beverages LLC 4 A.p. Deauville, LLC 4 Aaa Pharmaceutical, Inc. 4 Aap Implantate Ag 4

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Aaa Pharmaceutical, Inc. 4 Advanced Accelerator Applications USA, Inc. 4 Alkermes Inc 4 Allergan 4

Frequently Asked Questions

How many federal recall notices name Denton Pharma, Inc.? ▼
PlainRecalls indexes 4 distinct federal recall events naming Denton Pharma, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Denton Pharma, Inc. sit among other recalling firms? ▼
Denton Pharma, Inc. ranks #2,857 of 14,151 by distinct recall-event count among 14,151 firms in this archive (77th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Denton Pharma, Inc.'s notices? ▼
FDA Drug accounts for 4 of this firm's 4 indexed notices.
What product category dominates Denton Pharma, Inc.'s filing book? ▼
Filings for Denton Pharma, Inc. span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Denton Pharma, Inc.: 4 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Denton Pharma, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026